Cell-free circulating DNA as a novel biomarker in patients with the acute coronary syndrome

Cardiology (Switzerland)

Volumn 126, Issue 2, 2013, Pages 122-123

  Balta, Sevket ^a   Demirkol, Sait ^a   Cakar, Mustafa ^b   Karaman, Murat ^b   Ay, Seyit Ahmet ^b   Arslan, Zekeriya ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Eskisehir State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL FREE CIRCULATING DNA; DNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACUTE CORONARY SYNDROME; ERYTHROCYTE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE NECROSIS; HUMAN; LETTER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; THROMBOCYTE VOLUME;

ACUTE CORONARY SYNDROME; DNA; FEMALE; HUMANS; MALE;

EID: 84885030019     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000353266     Document Type: Letter

References (15)

1. Cui M, Fan M, Jing R, Wang H, Qin J, Sheng H, et al: Cell-free circulating DNA: a new biomarker for the acute coronary syndrome. Cardiology 2013; 124: 76-84.
2. Pedersen S, Mogelvang R, Bjerre M, Frystyk J, Flyvbjerg A, Galatius S, et al: Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Cardiology 2012; 123: 31-38.
3. Shimony A, Zahger D, Gilutz H, Goldstein H, Orlov G, Merkin M, et al: Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients. Acute Card Care 2010; 12: 109-111.
4. Steiner S, Jax T, Evers S, Hennersdorf M, Schwalen A, Strauer BE: Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 2005; 104: 92-96.
5. Ye L, Ma G-H, Chen L, Li M, Liu J-L, Yang K, et al: Quantification of circulating cell-free DNA in the serum of patients with obstructive sleep apnea-hypopnea syndrome. Lung 2010; 188: 469-474.
6. Kim BJ, Kim NH, Kim BS, Kang JH: The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals. Cardiology 2012; 123: 54-61.
7. Cingoz F, Iyisoy A, Demirkol S, Sahin MA, Balta S, Celik T, et al: Carotid intima-media thickness in patients with slow coronary flow and its association with neutrophil-to-lymphocyte ratio: a preliminary report. Clin Appl Thromb Hemost 2013, E-pub ahead of print.
8. Demirkol S, Balta S, Unlu M, Yuksel UC, Celik T, Arslan Z, et al: Evaluation of the mean platelet volume in patients with cardiac syndrome X. Clinics 2012; 67: 1019-1022.
9. Karaman M, Balta S, Ay SA, Cakar M, Naharci I, Demirkol S, et al: The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension. Clin Exp Hypertens 2013, E-pub ahead of print.
10. Unlu M, Karaman M, Ay SA, Balta S, Cakar M, Demirkol S, et al: The comparative effects of valsartan and amlodipine on vascular microinflammation in newly diagnosed hypertensive patients. Clin Exp Hypertens 2012, Epub ahead of print.
11. Cakar M, Balta S, Demirkol S, Kurt O, Unlu M, Akhan M: Red cell distribution width should be assessed together with other inflammatory markers in daily clinical practice. Cardiology 2013; 124: 60.
12. Haim M, Tanne D, Goldbourt U, Doolman R, Boyko V, Brunner D, et al: Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease. Cardiology 2007; 107: 52-56.
13. Petrovic D, Verhovec R, Globocnik Petrovic M, Osredkar J, Peterlin B: Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes. Cardiology 2007; 107: 291-295.
14. Vistnes M: Macrophage inflammatory protein-1β: a novel prognostic biomarker in atherosclerosis? Cardiology 2012; 121: 149-151.
15. Demirkol S, Balta S, Unlu M, Arslan Z, Cakar M, Kucuk U, et al: Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness. Clin Appl Thromb Hemost 2012, E-pub ahead of print.